HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

contrast agent BR1

consists of microbubbles containing sulfur hexafluoride stabilized by phospholipids
Also Known As:
SonoVue
Networked: 207 relevant articles (13 outcomes, 34 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Clevert, D-A: 6 articles (03/2010 - 01/2008)
2. Strobel, D: 5 articles (12/2012 - 05/2005)
3. Reiser, M: 5 articles (10/2011 - 01/2008)
4. Yang, Wei: 4 articles (01/2016 - 12/2005)
5. Lassau, Nathalie: 4 articles (04/2015 - 05/2006)
6. Lin, Win-Li: 4 articles (08/2012 - 10/2009)
7. Stock, K: 4 articles (01/2010 - 01/2008)
8. Jung, E M: 4 articles (01/2010 - 12/2007)
9. Bokor, D: 4 articles (12/2009 - 08/2000)
10. Luo, Wen: 4 articles (08/2009 - 05/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Hepatocellular Carcinoma (Hepatoma)
4. Coronary Artery Disease (Coronary Atherosclerosis)
10/01/2002 - "We report our clinical experience for diagnosis of coronary artery disease (CAD) and in particular, first experimental and clinical results with SonoVue, a new echo contrast agent."
11/01/2000 - "Two hundred and eighteen patients with suspected coronary artery disease undergoing fundamental echocardiography for the assessment of left ventricle were enrolled in a prospective multicenter, single blind, cross-over study with random sequence allocation of four different doses of SonoVue. "
08/17/2000 - "The possibility of detecting myocardial perfusion defects using SonoVue-enhanced power Doppler and gray-scale harmonic contrast echocardiography associated with continuous and intermittent imaging was assessed in patients with coronary artery disease. "
02/01/2000 - "Fifteen patients with known coronary artery disease and a resting perfusion abnormality on Tc-99m sestamibi single-photon emission computed tomography (SPECT) underwent PDHI at rest during intravenous injections of 2 to 3 mL of Sonovue (Bracco SpA, Milan, Italy), a new second-generation ultrasound contrast agent. "
10/08/2013 - "(A phase III study to compare SonoVue® enhanced myocardial echocardiography [MCE] to single photon emission computerized tomography [ECG-GATED SPECT], at rest and at peak of low-dose Dipyridamole stress test, in the assessment of significant coronary artery disease [CAD] in patients with suspect or known CAD using Coronary Angiography as Gold Standard-SonoVue MCE vs SPECT; EUCTR2007-003492-39-GR)."
5. Renal Cell Carcinoma (Grawitz Tumor)

Related Drugs and Biologics

1. Ethanol (Ethyl Alcohol)
2. Dipyridamole (Persantine)
3. Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
4. Contrast Media
5. Sulfur Hexafluoride
6. Sulfur
7. Caveolin 1
8. Thymidine Kinase
9. Antigens
10. SHU 508 (Levovist)

Related Therapies and Procedures

1. Microbubbles
2. Aftercare (After-Treatment)
3. Heterologous Transplantation (Xenotransplantation)
4. Decompressive Craniectomy
5. Quantum Dots (Quantum Dot)